General Information of This Linker
Linker ID
LIN0OACJX
Linker Name
DBCO-PEG4-VC-PABC- (PEG2)
Linker Type
Cathepsin-cleavable linker
Antibody-Linker Relation
Cleavable
Structure
Formula
C57H79N9O16
Isosmiles
CN(CCN(CCOCCO)C(O)=O)C(OCC1=CC=C(NC([C@@H](NC([C@@H](NC(CCOCCOCCOCCOCCNC(CCC(N2C3=C(C#CC(C=CC=C4)=C4C2)C=CC=C3)=O)=O)=O)C(C)C)=O)CCCNC(N)=O)=O)C=C1)=O
InChI
InChI=1S/C57H79N9O16/c1-41(2)52(54(72)62-47(12-8-23-60-55(58)73)53(71)61-46-18-14-42(15-19-46)40-82-57(76)64(3)25-26-65(56(74)75)27-31-79-32-28-67)63-50(69)22-29-77-33-35-80-37-38-81-36-34-78-30-24-59-49(68)20-21-51(70)66-39-45-11-5-4-9-43(45)16-17-44-10-6-7-13-48(44)66/h4-7,9-11,13-15,18-19,41,47,52,67H,8,12,20-40H2,1-3H3,(H,59,68)(H,61,71)(H,62,72)(H,63,69)(H,74,75)(H3,58,60,73)/t47-,52-/m0/s1
InChIKey
GYPKAJHPWYVRJQ-HWPOXGSQSA-N
Pharmaceutical Properties
Molecule Weight
1146.306
Polar area
328.29
Complexity
2480.713227
xlogp Value
2.556
Heavy Count
82
Rot Bonds
38
Hbond acc
15
Hbond Donor
8
Each Antibody-drug Conjugate Related to This Linker
Full Information of The Activity Data of The ADC(s) Related to This Linker
VC-PABC-DuoDM ADC [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 7 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
0.12&#1770.02 nM
High EREG expression (EREG +++)
Method Description
Colorectal cancer cells were plated at ~1,000 cells/well in 96-half-well plates. Serial dilutions of unconjugated H231, cmAb, H231 ADCs, or cADC were added and incubated at 37°C for 4 or 5 days. Cell viability was measured using CellTiter-Glo 2.0 (Promega, cat. #G9242) according to the manufacturer's protocol. Luminescence was measured using a Tecan Infinite M1000 plate reader (RRID: SCR_025732).

   Click to Show/Hide
In Vitro Model Colon adenocarcinoma LoVo cells CVCL_0399
Experiment 2 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
0.15&#1770.06 nM
High EREG expression (EREG +++)
Method Description
Colorectal cancer cells were plated at ~1,000 cells/well in 96-half-well plates. Serial dilutions of unconjugated H231, cmAb, H231 ADCs, or cADC were added and incubated at 37°C for 4 or 5 days. Cell viability was measured using CellTiter-Glo 2.0 (Promega, cat. #G9242) according to the manufacturer's protocol. Luminescence was measured using a Tecan Infinite M1000 plate reader (RRID: SCR_025732).

   Click to Show/Hide
In Vitro Model Colon carcinoma HCT116 cells CVCL_0291
Experiment 3 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
0.33&#1770.093 nM
Moderate EREG expression (EREG++)
Method Description
Colorectal cancer cells were plated at ~1,000 cells/well in 96-half-well plates. Serial dilutions of unconjugated H231, cmAb, H231 ADCs, or cADC were added and incubated at 37°C for 4 or 5 days. Cell viability was measured using CellTiter-Glo 2.0 (Promega, cat. #G9242) according to the manufacturer's protocol. Luminescence was measured using a Tecan Infinite M1000 plate reader (RRID: SCR_025732).

   Click to Show/Hide
In Vitro Model Colon adenocarcinoma SW48 cells CVCL_1724
Experiment 4 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
0.52&#1770.39 nM
High EREG expression (EREG +++)
Method Description
Colorectal cancer cells were plated at ~1,000 cells/well in 96-half-well plates. Serial dilutions of unconjugated H231, cmAb, H231 ADCs, or cADC were added and incubated at 37°C for 4 or 5 days. Cell viability was measured using CellTiter-Glo 2.0 (Promega, cat. #G9242) according to the manufacturer's protocol. Luminescence was measured using a Tecan Infinite M1000 plate reader (RRID: SCR_025732).

   Click to Show/Hide
In Vitro Model Colon adenocarcinoma DLD-1 cells CVCL_0248
Experiment 5 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50) > 10000 nM Negative EREG expression (EREG-)
Method Description
Colorectal cancer cells were plated at ~1,000 cells/well in 96-half-well plates. Serial dilutions of unconjugated H231, cmAb, H231 ADCs, or cADC were added and incubated at 37°C for 4 or 5 days. Cell viability was measured using CellTiter-Glo 2.0 (Promega, cat. #G9242) according to the manufacturer's protocol. Luminescence was measured using a Tecan Infinite M1000 plate reader (RRID: SCR_025732).

   Click to Show/Hide
In Vitro Model Colon adenocarcinoma DLD-1 cells (EREG KO) CVCL_0248
Experiment 6 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50) > 10000 nM Low EREG expression (EREG+)
Method Description
Colorectal cancer cells were plated at ~1,000 cells/well in 96-half-well plates. Serial dilutions of unconjugated H231, cmAb, H231 ADCs, or cADC were added and incubated at 37°C for 4 or 5 days. Cell viability was measured using CellTiter-Glo 2.0 (Promega, cat. #G9242) according to the manufacturer's protocol. Luminescence was measured using a Tecan Infinite M1000 plate reader (RRID: SCR_025732).

   Click to Show/Hide
In Vitro Model Colon adenocarcinoma SW620 cells CVCL_0547
Experiment 7 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50) > 10000 nM Low EREG expression (EREG+)
Method Description
Colorectal cancer cells were plated at ~1,000 cells/well in 96-half-well plates. Serial dilutions of unconjugated H231, cmAb, H231 ADCs, or cADC were added and incubated at 37°C for 4 or 5 days. Cell viability was measured using CellTiter-Glo 2.0 (Promega, cat. #G9242) according to the manufacturer's protocol. Luminescence was measured using a Tecan Infinite M1000 plate reader (RRID: SCR_025732).

   Click to Show/Hide
In Vitro Model Colon carcinoma RKO cells CVCL_0504
References
Ref 1 Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Anti-Tumor Activity in Colorectal Cancer